Participate in a Study

The IMMUNOSYMPTOM Study

Currently recruiting participants to study immunotherapy, the gut microbiome, and adverse symptoms.

You may be eligible if you are:

  • Ages 18-80
  • Currently receiving immunotherapy treatment
  • Willing to participate in a one-time, two-hour study session
  • Able to communicate in English

 

Learn more

The AISLEEP Study

Currently recruiting participants to study sleep disturbances and pain in breast cancer survivors on aromatase inhibitors.

You may be eligible if you are:

  • Currently receiving the standard dose of aromatase inhibitor therapy (e.g. anastrozole, letrozole, exemestane, etc.)
  • Ages 30-79
  • Willing to participate in a one-time, one-hour study session

 

Learn more

The CARING Study

Currently recruiting participants to study the roles of sleep/circadian rhythm, mental health, and biological stress.

You may be eligible if you are:

  • A caregiver with a child 3-4 years old
  • Able to speak and read English

Learn more

The Diabetes and Low Back Pain Study

Currently recruiting participants to a study that is identifying symptoms experienced, skills used to manage health, sensory function, and inflammatory, metabolic and genetic markers among people with one condition (either diabetes type 2, OR chronic low back pain), OR people with both conditions (diabetes and chronic low back pain).

You may be eligible if you are:

  • Ages 18 and older
  • Have a smartphone
  • Have low back pain for at least 3 of the last 6 months, OR have type 2 diabetes with low back pain, OR have type 2 diabetes alone.

 

Learn more

The AIMIC Study

Currently recruiting participants to study the role of gut microbiome in aromatase inhibitor-associated musculoskeletal symptoms and bone health in breast cancer survivors.

You may be eligible if you are:

  • Currently receiving the standard dose of aromatase inhibitor therapy (e.g. anastrozole, letrozole, exemestane, etc.)
  • Ages 30-79
  • Willing to participate in a one-time, two-hour study session

 

Learn more

The SPINE Study

The Sensitivity to Pain IN mE (SPINE), is designed to increase individuals’ self-management knowledge and skills for activating pain modulatory pathways that are known to reduce nociceptive signaling and expression of pain sensitivity genes. 

Learn more

The MCOV Study

Currently recruiting participants to study the impact of the gut microbiome on human immune responses to COVID-19.

You may be eligible if you are:

  • Age 18 or older
  • Able to speak and read English
  • Able to provide and give informed consent to participate
  • Plan to receive or recently received a COVID-19 vaccine

 

Learn more

The PATH Study

Currently recruiting participants for a study evaluating the benefits of movement and physical activity intervention among people with chronic low back pain.

You may be eligible if you are:

  • Age 18 or older
  • Have had low back pain for at least 3 of the last 6 months
  • Have not practiced movement-based exercise in the past 3 months and are willing to attend 12 weeks of movement exercises
  • Able to speak and read English

 

Learn more